Antibiotic Therapy For Mediastinitis
Published on: August 29, 2024
Antibiotic Therapy For Mediastinitis
Article author photo

Nyim Hussain

Article reviewer photo

Hartlee Soledad Openiano

BSc Applied Anatomy, University of Bristol

Introduction

Mediastinitis is a serious infection of the mediastinum, the middle compartment of the thoracic cavity, generally occurring after cardiac or chest surgery. Early diagnosis and treatment are vital, as mediastinitis can result in severe morbidity and mortality. Antibiotic therapy for mediastinitis is one of the main treatments to eradicate the infection and prevent further complications. This article explores the role of antibiotics in treating mediastinitis, outlining key research findings and clinical practices.

Understanding mediastinitis

There are two types of mediastinitis:

Acute mediastinitis 

This is often caused by oesophageal perforation (puncture) or postoperative infections, particularly following cardiac surgery. It typically presents with a rapid onset of symptoms and requires urgent medical intervention.

Chronic mediastinitis 

This usually results from granulomatous infections like tuberculosis (TB) or histoplasmosis. It progresses slowly and is often associated with fibrosis (scarring) in the mediastinum.

Causes and risk factors

The common causes and risk facts for mediastinitis include:

Postoperative infections

Mediastinitis is a known complication following cardiac surgery, especially with procedures involving sternotomy.

Trauma or perforation

Injury to the oesophagus or other structures within the thoracic cavity can introduce pathogens (bacteria and viruses) into the mediastinum.

Spread of infection

Head, neck, or lung infections can extend into the mediastinum, leading to mediastinitis.

Benefits and effects of antibiotic therapy

Antibiotics work by, either, killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic). The choice of antibiotic depends on the type of bacteria causing the infection and their susceptibility patterns. Here are the commonly used antibiotics based on scientific research:

Linezolid and MRSA 

High doses of linezolid, alone or in combination with rifampin, have been shown to reduce bacterial counts in cases of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis. 

Research indicates that combination therapy did not significantly outperform linezolid alone.1

Hyperbaric oxygen therapy (HBO)

HBO, when used alongside antibiotics like linezolid, teicoplanin, or vancomycin, significantly enhances treatment efficacy by reducing bacterial counts more effectively than antibiotics alone.2

Vancomycin and linezolid in heart transplant patients 

Prolonged aggressive antibiotic therapy with vancomycin and linezolid, combined with local irrigation, has successfully treated severe MRSA mediastinitis post-heart transplantation.3

Daptomycin 

Clinical improvement was observed in 90.5% of patients with mediastinitis post-cardiac surgery when daptomycin was used as supportive therapy, demonstrating its efficacy and tolerability.4

Anaerobic infections 

Mediastinitis caused by anaerobic bacteria such as Bacteroides and Peptostreptococcus requires appropriate antibacterial therapy targeting, both, aerobic and anaerobic pathogens.5

Bacitracin ointment 

Topical application of bacitracin ointment post-sternotomy has been shown to significantly reduce the risk of postoperative mediastinitis, highlighting its preventive potential.6

Dosage and usage guidelines

Standard protocols

Acute mediastinitis 

This type of mediastinitis is typically treated with broad-spectrum antibiotics until the specific pathogen is identified. Empirical therapy often includes vancomycin combined with either a beta-lactam or an aminoglycoside e.g., amoxicillin.

Chronic mediastinitis 

Treatment may require a prolonged course of antibiotics, often adjusted based on the specific pathogen and its antibiotic susceptibility.

Duration of treatment

The length of antibiotic therapy can vary but generally ranges from 4 to 6 weeks, depending on the severity of the infection and the patient’s response to treatment. As with all bacterial infections, it is crucial to complete the full course to prevent the development of antibiotic resistance. This is when a small population of bacteria survive and can be resistant to this specific antibiotic.

Safety and side effects

Common side effects

Gastrointestinal issues are common, such as: 

Allergic reactions can also occur, ranging from mild skin rashes to severe anaphylaxis.

Adverse reactions and contraindications

Patients with known allergies to specific antibiotics should avoid those medications. Monitoring is essential for those at risk of severe reactions. Alternative treatments should be considered for patients unable to tolerate standard antibiotics.

Combining with other treatments

Surgical interventions

Surgery is often necessary to remove infected tissue, drain abscesses/ulcers, or repair perforations (punctures). Antibiotic therapy is used in conjunction with these procedures to control the infection. 

Surgery is typically the last port of call as it is an invasive procedure.

Other therapies

Antifungal or antiviral agents may be needed if the infection involves fungal or viral pathogens. Supportive treatments like drainage and debridement are crucial for effective management.

FAQs

What are the common symptoms of mediastinitis? 

Symptoms include: 

How is mediastinitis diagnosed? 

Diagnosis typically involves imaging studies such as CT scans, blood cultures, and, sometimes, direct sampling of mediastinal fluid.

Which antibiotics are most effective for treating mediastinitis?

Effective antibiotics include linezolid, vancomycin, daptomycin, and combinations, depending on the causative bacteria.

What are the potential side effects of antibiotic therapy for mediastinitis?

Common side effects include gastrointestinal issues and allergic reactions. Severe adverse reactions may require alternative treatments.

Summary

  • Mediastinitis requires prompt and effective treatment to prevent severe complications 
  • Antibiotic therapy plays a vital role in managing this condition, with specific protocols tailored to the type of mediastinitis and the causative pathogens
  • Research highlights the efficacy of various antibiotics in treating mediastinitis, with supportive therapies like HBO and topical bacitracin also showing significant benefits
  • Understanding the appropriate usage, potential side effects, and the need for combining treatments can enhance patient outcomes

References

  1. Saçar M, Saçar S, Kaleli İ, Cevahir N, Teke Z, Kavas S, et al. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study. Int J Infect Dis. 2008 [cited 17 June 2024]; 12(4):396-401. Available from: https://www.sciencedirect.com/science/article/pii/S1201971207002111 
  2. Turhan V, Saçar S, Uzun G, Saçar M, Yıldız Ş, Ceran N, et al. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis. J Surg Res. 2009 [cited 17 June 2024]; 155(1):111-5. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0022480408005672 
  3. Pasic M, Schaffarczyk R, Hetzer R. Successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a heart transplant recipient. Eur J Cardiothorac Surg. 2004 [cited 17 June 2024]; 25(6):1127-8. Available from: https://academic.oup.com/ejcts/article/25/6/1127/380583  
  4. Weis F, Heyn J, Hinske C, Vogt F, Weis M, Kur F, et al. Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery. J Cardiothorac Surg. 2012 [cited 17 June 2024]; 7:81. Available from: https://link.springer.com/article/10.1186/1749-8090-7-81  
  5. Brook I. The role of anaerobic bacteria in mediastinitis. Drugs. 2012 [cited 17 June 2024]; 66:315-20. Available from: https://link.springer.com/article/10.2165/00003495-200666030-00004  
  6. MacIver R, Stewart R, Frederiksen J, Fullerton D, Horvath K. Topical application of bacitracin ointment is associated with decreased risk of mediastinitis after median sternotomy. Heart Surg Forum. 2006 [cited 17 June 2024]; 9(5). Available from: https://journal.hsforum.com/index.php/HSF/article/view/262  
Share

Nyim Hussain

arrow-right